Sign in
4

Changes in Ownership

Cabaletta Bio, Inc. Filed Acc 0000950170-25-074818

Options or other derivatives

  • Chief Financial Officer acquired 745,456 shares (grant or award)
  • Chief Financial Officer returned 745,456 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −139,282 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +139,282 139,282 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −66,463 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +66,463 66,463 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −24,711 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +24,711 24,711 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −100,000 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +100,000 100,000 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −135,000 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +135,000 135,000 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −150,000 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +150,000 150,000 D
Marda Anup Chief Financial Officer 2025-05-19 Returned to the company · Stock Option (Right to Buy) −130,000 0 D
Marda Anup Chief Financial Officer 2025-05-19 Grant or award · Stock Option (Right to Buy) +130,000 130,000 D
Loading xslF345X05/ownership.xml…